Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Finance Receivables	38.99M	27.51M	33.66M	31.64M	38.94M
Finance Receivables Growth	41.76%	-18.27%	6.37%	-18.74%	28.28%
Pharmaceutical Development and Other	2.25M	3.64M	1.20M	6.01M	16.85M
Pharmaceutical Development and Other Growth	-38.11%	203.00%	-80.01%	-64.33%	185.36%
Holding Company and Other	-3.66M	-3.60M	-858.00K	5.00K	-
Total	37.58M	27.55M	34.00M	37.65M	55.78M
Total Growth	36.44%	-18.98%	-9.70%	-32.50%	53.85%

Source: S&P Global Market Intelligence.